Oncolytics Biotech Inc. (TSE:ONC – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Friday . The company traded as low as C$0.86 and last traded at C$0.88, with a volume of 6500 shares trading hands. The stock had previously closed at C$0.90.
Oncolytics Biotech Stock Down 5.6 %
The firm’s 50 day moving average price is C$1.02 and its 200-day moving average price is C$1.27. The company has a current ratio of 2.99, a quick ratio of 8.86 and a debt-to-equity ratio of 11.75. The company has a market cap of C$65.51 million, a P/E ratio of -2.37 and a beta of 1.35.
About Oncolytics Biotech
Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.
Featured Articles
- Five stocks we like better than Oncolytics Biotech
- Dividend Capture Strategy: What You Need to Know
- MarketBeat Week in Review – 03/24 – 03/28
- Using the MarketBeat Stock Split Calculator
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Transportation Stocks Investing
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Oncolytics Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncolytics Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
